Antibody Titration in Hemolytic Disease of the Fetus and Newborn - State of the Art

被引：0

作者：

Flommersfeld, Sabine ^{[1
]}

Ertl, Birgit ^{[1
]}

机构：

[1] Univ Klinikum Giessen & Marburg, Zentrum Transfus Med & Hamotherapie, Baldingerstr, D-35043 Marburg, Germany

来源：

TRANSFUSIONSMEDIZIN | 2018年 / 8卷 / 02期

关键词：

alloimmunization; antibody titration; hemolytic disease of the newborn;

D O I：

10.1055/s-0043-121113

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Immunohematological results may not correlate with the clinical outcome of patients. Especially in fetomaternal incompatibility it would be desirable to have a validated method for prediction of the clinical relevance of an antibody. Antibody titration is widely used. Quality controls are not standardized and methods and interpretation of results differ. A reliable method for antibody titration is described and its pro's and con's will be discussed.

引用

页码：90 / 94

页数：5

共 50 条

[21] Hemolytic disease of the fetus and newborn-a perspective of immunohematology
Rodrigues, Mirelen Moura de Oliveira
Mattos, Denise
Almeida, Silvana
Fiegenbaum, Marilu
HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2024, 46 : S246 - S257
[22] Hemolytic disease of the fetus and newborn caused by an antibody to a low-prevalence antigen, anti-SARA
Towns, Dale
Hannon, Judith
Hendry, Julia
Barnes, Janet
Goldman, Mindy
TRANSFUSION, 2011, 51 (09) : 1977 - 1979
[23] A Rare Case of Hemolytic Disease of the Fetus and Newborn Caused by Anti-s Antibody in a Chinese Patient
Liyan, Yang
Yongmei, Jiang
Jing, Feng
CLINICAL LABORATORY, 2023, 69 (04) : 798 - 801
[24] Janssen's nipocalimab tackles hemolytic disease of the fetus and newborn
Carvalho, Thiago
NATURE MEDICINE, 2023, 29 (04) : 757 - 758
[25] Duration of hemolysis among infants with hemolytic disease of the fetus and newborn
Bahr, Timothy M.
Moise Jr, Kenneth J.
Lowry, Kathy
Monson, Martha A.
Hammad, Ibrahim A.
Goteti, Sasidhar
Ilstrup, Sarah J.
Vanasco, Paul
Ohls, Robin K.
Christensen, Robert D.
JOURNAL OF PERINATOLOGY, 2025, 45 (02) : 268 - 270
[26] Hemolytic disease of the fetus and newborn caused by anti-Lan
Brooks, Sarah
Squires, Jerry E.
TRANSFUSION, 2014, 54 (05) : 1317 - 1320
[27] Noninvasive approaches to the management of RhD hemolytic disease of the fetus and newborn
Urbaniak, S. J.
TRANSFUSION, 2008, 48 (01) : 2 - 5
[28] Comparison of intrauterine transfusion techniques in hemolytic disease of the fetus and newborn
van't Oever, R. M.
van Duijn, V. M.
Slaghekke, F.
Haak, M. C.
de Winter, D. P.
Lopriore, E.
de Haas, M.
Le Cessie, S.
Verweij, E. J. T.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2025,
[29] Variations and Opportunities in Postnatal Management of Hemolytic Disease of the Fetus and Newborn
de Winter, Derek P.
Verweij, E. J. T.
Debeer, Anne
Devlieger, Roland
Lewi, Liesbeth
Verbeeck, Sarah
Maurice, Paul
Jouannic, Jean-Marie
Guillemin, Marie-Gabrielle
Mailloux, Agnes
dos Santos, Maria Cristina Pessoa
Pacheco, Cynthia Amaral de Moura Sa
Moreira, Maria Elisabeth Lopes
Vaena, Marcella Martins de Vasconcelos
Bohlin, Kajsa
Tiblad, Eleonor
Thorup, Emilie
Petersen, Olav Bjorn
Sanchez-Holgado, Maria
Llorente, Aurora Viejo
Poljak, Borna
Khalil, Asma
Le Duc, Kevin
Ghesquiere, Louise
Krivec, Jana Lozar
Soltirovska-Salamon, Aneta
Dame, Christof
Blank, Jessica D.
Hohnecker, Alexander
Saxonhouse, Matthew
Connors, Ngina K.
Geipel, Annegret
Rath, Johanna
Prasad, Smriti
van Wyk, Lizelle
Geerts, Lut
Schuler, Rahel
Thon, Nina
Leibovitch, Leah
Cohen, Stav
Canul-Euan, Arturo Alejandro
Kelly, Edmond
Raghuram, Kamini
Cavigioli, Francesco
Colombo, Sofia Fatima Guiseppina
Elanjikal, Ziju
Brayley, Jessica
Pfurtscheller, Daniel
Pichler, Gerhard
Grisi, Angel Guillermo Alcazar
JAMA NETWORK OPEN, 2025, 8 (01)
[30] Hemolytic Disease of the Fetus and Newborn due to Intravenous Drug Use
Markham, Kara B.
Scrape, Scott R.
Prasad, Mona
Rossi, Karen Q.
O'Shaughnessy, Richard W.
AJP REPORTS, 2016, 6 (01): : E129 - E132

← 1 2 3 4 5 →